VANCOUVER, British Columbia, Nov. 15, 2007 (PRIME NEWSWIRE) -- Zecotek Medical Systems, Inc. (TSX-V:ZMS) (Frankfurt:W1I) today announced the selection of its CW Ti: Sapphire laser, model TIS-FD-08/A-scan-WV, by the Institute for Quantum Computing, University of Waterloo, Canada. The laser is the latest ultra-wide tunable laser to be developed by Zecotek and will be used by the Institute in the field of nano-optics (the investigation of single semiconductor quantum dots) and quantum computing.
"We are very pleased that the University of Waterloo's prestigious Institute for Quantum Computing has selected our latest CW Ti: Sapphire laser," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. "Our new auto-scanned narrow band Ti: Sapphire laser is a valuable tool in this important area of research and is another example of Zecotek's strength in the innovation and commercialization of leading edge photonic technologies."
Zecotek's CW narrow-band Ti: Sapphire laser, with computer control and integrated wave meter, represents the optimal cost-effective solution for a source of radiation tuneable within a wide range of wavelengths, important features for spectroscopy of semiconductor materials and other advanced material and scientific applications.
Zecotek's Ti: Sapphire lasers are manufactured under contract by Tekhnoscan Lasers of Novosibirsk, for Zecotek Laser Systems Pte Ltd., the company's wholly owned subsidiary.
About the Institute for Quantum Computing, University of Waterloo
The mission of the Institute is to advance fundamental experimental and theoretical knowledge in relevant areas of Engineering, Mathematics and Science to enhance the developments in the field of Quantum Computation and Information Processing. This is to be achieved by providing a unique facility and environment to bring together some of the best researchers and students in computing, engineering, mathematical and physical sciences. For more information, please visit www.iqc.ca.
About Zecotek
Zecotek Medical Systems (TSX-V:ZMS) (Frankfurt:W1I) is a photonics technology company developing high-performance crystals, photo detectors, lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industry. Founded in 2003, the company has three distinct operating divisions: imaging, lasers and 3D display and labs located in Canada, Singapore and Russia. Zecotek commercializes its novel, patented and patent-pending bio-photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit www.zecotek.com.
The Zecotek Medical Systems logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3001
This press release may contain forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.